dNovo
InactiveThe cure for hair loss.
What it does
At dNovo, we are curing hair loss by creating new hair, de novo. We are doing this with cellular reprogramming technology that we pioneered at Stanford and Harvard. With this technology, we can take any patient derived cell, whether it be blood, skin or fat and reprogram (convert) them into medically relevant cell types. Our first objective is to cure hair loss by using our reprogramming technology to make new hair (patent pending). This is different from everything currently available on the market because the hair loss industry is focused on maintaining the hair that you already have, but no one is trying to produce NEW hair, de novo. After hair, we envision using our cellular reprogramming technique to make any cell, any tissue or any organ on demand to replace what is lost as we age.
Its site says now · captured 2026-08-23
dNovo - Home
At dNovo, we regenerate hair stem cells.
Next to it in Healthcare and bio · Cellular reprogramming for hair regeneration
- ExcepgenY Combinator W19
ExcepGen
- バイオス株式会社Plug and Play
Bios is a company which built a solid alliance with professors who conduct cutting-edge research
- Toregem Bio Pharma Co., Ltd.Plug and Play
Tooth regeneration therapy / 歯の再生治療薬
- Dorian TherapeuticsY Combinator S18
New therapeutics to rejuvenate tissue and treat age-related diseases
- Gerostate AlphaY Combinator S18
Developing novel therapeutics for aging and chronic disease
- Pine Park HealthY Combinator S18
We provide primary care in senior living communities.
- Civetbio500 Global
Provider of biotechnology service intended to accelerate drug discovery for live bio-therapeutics. The company's service includes a microbiota bank, a clinical intervention platform, and core big data technology that powers their bioinformatics pipeline, enabling researchers to characterize the Asian gut microbiome and understand the varying profiles across country regions.
- Orthox Ltd.Plug and Play
Orthox develops tissue regenerative implants that address large injuries to cartilage tissues in which early osteoarthritis may be present.